The fibrinolytic activity of urine.
作者信息
WILLIAMS J R B
出版信息
Br J Exp Pathol. 1951 Dec;32(6):530-7.
Abstract
摘要
相似文献
1
The fibrinolytic activity of urine.
Br J Exp Pathol. 1951 Dec;32(6):530-7.
2
[On the fibrinolytic effect of urine; inhibition of urinary fibrinolysis after subcutaneous injection of hyaluronidase].
Enzymologia. 1953 Apr 15;16(1):56-61.
3
Profibrinolysin, antifibrinolysin, fibrinogen and urine fibrinolytic factors in the human subject.
J Clin Invest. 1954 Nov;33(11):1553-9. doi: 10.1172/JCI103033.
4
Prolonged activation of fibrinolytic system induced by fibrin nonselective thrombolytic agent can contribute to preventing early reocclusion after coronary thrombolytic therapy.
Cardiology. 1993;82(4):274-9. doi: 10.1159/000175875.
5
Use of fluorescein-labeled fibrin for the determination of fibrinolytic activity.
J Lab Clin Med. 1962 Jun;59:1039-46.
6
Clinical determination of fibrinolytic activity; an evaluation of some methods.
AMA Arch Surg. 1959 Apr;78(4):639-46. doi: 10.1001/archsurg.1959.04320040133027.
7
[Fibrinolytic activity of the blood plasma in normal subjects].
Pol Arch Med Wewn. 1956;26(9):1321-8.
8
Fibrinolytic activity in human saliva.
Acta Physiol Scand. 1955 Dec 31;35(2):138-45. doi: 10.1111/j.1748-1716.1955.tb01272.x.
9
Studies on enhanced fibrinolytic activity in man.
J Clin Invest. 1959 May;38(5):810-22. doi: 10.1172/JCI103863.
10
Fibrinolytic activity of human blood after death.
Acta Physiol Scand. 1952;27(2-3):265-71. doi: 10.1111/j.1748-1716.1953.tb00942.x.
引用本文的文献
1
Thrombolytic Agents: Nanocarriers in Controlled Release.
Small. 2020 Oct;16(40):e2001647. doi: 10.1002/smll.202001647. Epub 2020 Aug 12.
2
Translational initiatives in thrombolytic therapy.
Front Med. 2017 Mar;11(1):1-19. doi: 10.1007/s11684-017-0497-8. Epub 2017 Mar 2.
3
Proteases as therapeutics.
Biochem J. 2011 Apr 1;435(1):1-16. doi: 10.1042/BJ20100965.
4
Differentiating pharmacologic agents used in catheter-directed thrombolysis.
Semin Intervent Radiol. 2005 Jun;22(2):121-9. doi: 10.1055/s-2005-871867.
5
Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.
Breast Care (Basel). 2008;3(s2):3-10. doi: 10.1159/000151737. Epub 2008 Oct 15.
6
Symposium on Fibrinolysis.
Proc R Soc Med. 1963 May;56(5):407-10. doi: 10.1177/003591576305600534.
7
[STUDIES ON THE PROTEOLYTIC ACTIVITY OF URINE FROM GUINEA PIGS IN ALLERGIC REACTIONS].
Arch Klin Exp Dermatol. 1964 Sep 10;220:321-8.
8
THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.
J Clin Pathol. 1964 Sep;17(5):520-30. doi: 10.1136/jcp.17.5.520.
9
The enhancement of chloroform-induced plasma proteolytic activity by epsilon aminocaproic acid.
J Exp Med. 1962 Apr 1;115(4):695-706. doi: 10.1084/jem.115.4.695.
10
On the controlling function of the kidneys in fibrinolysis.
Experientia. 1962 Mar 15;18:146-7. doi: 10.1007/BF02153867.
本文引用的文献
1
Studies on the activation and purification of blood fibrinolysin.
Biochem J. 1948;43(2):163-8.
2
ACTIVATION OF PROPLASMIN BY A FACTOR FROM MAMMALIAN TISSUE.
J Clin Invest. 1950 Mar;29(3):317-24. doi: 10.1172/JCI102260.
3
Studies on a proteolytic enzyme system of the blood. II. Fibrinolysokinase activators for profibrinolysin.
J Clin Invest. 1950 Aug;29(8):1059-68. doi: 10.1172/JCI102337.
Zotero 插件